10% Off
Nytenso10 mg
Incepta Pharmaceuticals Ltd.
৳180.00
Add to cart
Vortiox10 mg
Tablet
By
Best PriceTk /
1
Medicine overview
Indications of Vortiox 10 mg
Vortiox 10 mg is indicated for the treatment of Major Depressive Disorder (MDD) in adults. It is used to help manage and improve symptoms associated with clinical depression.
Primary Use
- Major Depressive Disorder (MDD) in adults
Therapeutic Benefit
Vortiox 10 mg helps support the management of depressive symptoms such as:
- Persistent low mood
- Loss of interest or pleasure in daily activities
- Emotional and functional impairment associated with depression
Theropeutic Class
Serotonin-norepinephrine reuptake inhibitor (SNRI)
Pharmacology
The exact mechanism of antidepressant action of Vortiox 10 mg (Vortioxetine) is not completely understood.
Absorption
However, its therapeutic effects are primarily linked to modulation of serotonergic activity in the central nervous system (CNS).
Distribution
Primary Mechanism Enhances serotonin (5-HT) neurotransmission by inhibiting serotonin reuptake Increases overall serotonergic activity in brain pathways associated with mood regulation Receptor Activity In addition to serotonin reuptake inhibition, Vortioxetine acts on multiple serotonin receptors, including: 5-HT3 receptor antagonism (blocks receptor activity) 5-HT1A receptor agonism (stimulates receptor activity) Therapeutic Effect Through these combined actions, Vortiox 10 mg helps improve mood, emotional stability, and cognitive symptoms associated with Major Depressive Disorder (MDD).
Dosage & Administration of Vortiox 10 mg
The dosage of Vortiox 10 mg (Vortioxetine) should be individualized based on patient response, tolerability, and clinical condition. It is administered orally once daily, with or without food.
Recommended Starting Dose
- The usual initial dose is 10 mg once daily
- If tolerated, the dose may be increased to 20 mg once daily
- Doses above 20 mg/day have not been evaluated for safety or efficacy in clinical studies
Dose Adjustment
- For patients who do not tolerate higher doses, the dose may be reduced to 5 mg once daily
- In elderly patients (above 65 years), treatment should start with the lowest effective dose of 5 mg once daily
Maintenance Therapy
- Vortiox 10 mg may be continued for several months or longer in the treatment of Major Depressive Disorder (MDD)
- Long-term treatment should be regularly reviewed to assess ongoing benefit and necessity
Discontinuation of Treatment
- Although Vortiox 10 mg can be stopped abruptly, some patients may experience temporary withdrawal symptoms, such as:
- Headache
- Muscle tension
- To reduce these effects, it is recommended to:
- Reduce the dose to 10 mg daily for 1 week before complete discontinuation (especially from 15–20 mg doses)
Switching with MAO Inhibitors (MAOIs)
To avoid the risk of serotonin syndrome:
- Allow at least 14 days after stopping an MAOI before starting Vortiox 10 mg
- Allow at least 21 days after stopping Vortiox 10 mg before initiating an MAOI
Interaction of Vortiox 10 mg
Vortiox 10 mg (Vortioxetine) may interact with several medications, particularly those affecting serotonin levels or liver enzyme metabolism. Careful monitoring or dose adjustment may be required.
Monoamine Oxidase Inhibitors (MAOIs)
Concomitant use with MAO inhibitors is contraindicated due to a high risk of serious and potentially life-threatening reactions
Severe adverse effects may occur when:
Vortiox 10 mg is started soon after stopping an MAOI, or
An MAOI is started shortly after discontinuing Vortiox 10 mg
Serotonergic Drugs
Co-administration with other serotonin-enhancing medications may increase the risk of serotonin syndrome , including:
SSRIs and SNRIs
Tryptophan-containing products
Patients should be closely monitored for symptoms of serotonin toxicity. If serotonin syndrome is suspected, all serotonergic agents must be stopped immediately .
Other CNS Active Drugs
No clinically significant interaction has been observed with lithium at steady state when used with Vortiox 10 mg
Effect of Other Drugs on Vortiox 10 mg CYP2D6 Inhibitors
Strong CYP2D6 inhibitors (e.g., bupropion, fluoxetine, paroxetine, quinidine ) may increase Vortioxetine levels
Recommended action—reduce Vortiox 10 mg dose by 50%
CYP Enzyme Inducers
Strong enzyme inducers (e.g., rifampin, carbamazepine, phenytoin ) may reduce drug effectiveness
Dose adjustment upward may be considered based on clinical response
Contraindications
Vortiox 10 mg is contraindicated in Patients with known hypersensitivity to Vortioxetine or any of the excipients of the drug product & concomitant use of Monoamine Oxidase Inhibitors (MAOIs).
Side Effects of Vortiox 10 mg
Vortiox 10 mg (Vortioxetine) may cause some adverse effects in certain patients, although not everyone experiences them.
Possible Side Effects
- Hypersensitivity reactions such as rash or itching
- Worsening depression or suicidal thoughts, especially early in treatment
- Serotonin syndrome (rare but serious)
- Abnormal bleeding, particularly with blood thinners or NSAIDs
- Mania or hypomania activation in predisposed patients
- Angle-closure glaucoma (rare eye complication)
- Hyponatremia (low sodium levels, more common in elderly)
Note
Patients should be monitored during treatment, and any severe or unusual symptoms should be reported to a healthcare professional immediately.
Pregnancy & Lactation
Pregnancy
The safety of Vortiox 10 mg (Vortioxetine) during pregnancy has not been well established. Therefore, it should not be used during pregnancy or in women planning pregnancy, unless the potential benefits clearly outweigh the possible risks to the fetus.
Breastfeeding (Lactation)
Animal studies suggest that Vortioxetine and its metabolites may be excreted in breast milk, and it is expected to pass into human milk as well. Since a risk to the nursing infant cannot be ruled out, breastfeeding is not recommended during treatment with Vortiox 10 mg.
Precautions & Warnings
Clinical Worsening & Suicidal Risk
Patients receiving antidepressants, including Vortiox 10 mg, should be closely monitored—especially during the initial weeks of treatment or dose changes—for:
- Worsening depression
- Suicidal thoughts or behavior
- Unusual changes in mood or behavior
Serotonin Syndrome
A potentially life-threatening condition may occur, particularly when Vortiox 10 mg is used with other serotonergic drugs such as:
- Triptans, tramadol, lithium, fentanyl
- Tricyclic antidepressants, buspirone, tryptophan
- St. John’s Wort
- MAOIs (including linezolid and methylene blue)
Abnormal Bleeding
Vortiox 10 mg may increase bleeding risk, especially when combined with:
- Aspirin or NSAIDs
- Warfarin and other anticoagulants
Mania / Hypomania
Use with caution in patients with a history of bipolar disorder, as antidepressants may trigger manic or hypomanic episodes.
Angle-Closure Glaucoma
Antidepressants may cause pupil dilation, which can trigger acute angle-closure glaucoma in susceptible individuals with narrow eye angles.
Hyponatremia
Low sodium levels may occur due to serotonergic effects, particularly in elderly patients.
Overdose Effects of Vortiox 10 mg
There is limited data available on Nytenso overdose. Medical follow-up in a specialized environment is recommended.
Storage Conditions
Store at 30°C or below in a dry place. Keep away from light. Keep out of the reach of the children.
Use In Special Populations
Pediatric Use (<18 years)
- The safety and effectiveness of Vortiox 10 mg in children and adolescents have not been established
- Not recommended for use in this age group
Geriatric Use (≥65 years)
- No dose adjustment is required based on age
- Pharmacokinetic studies show similar drug exposure in elderly and younger adults
Renal Impairment
- No dose adjustment is needed in patients with kidney impairment
Hepatic Impairment
- No dose adjustment is required in mild to moderate liver impairment
- Use is not recommended in severe hepatic impairment
CYP2D6 Poor Metabolizers
- Drug exposure may be approximately 2 times higher in CYP2D6 poor metabolizers
- Exposure may further increase with strong CYP3A4/2C9 inhibitors
- Dose adjustment may be required based on clinical response
Other Populations
- No dose adjustment is required based on race, gender, or ethnicity
Frequently Asked Questions
What is Vortiox 10 mg used for?
Vortioxetine Hydrobromide is indicated for the treatment of Major Depressive Disorder (MDD) in adults. It is used to help manage and improve symptoms associated with clinical depression. Primary Use Major Depressive Disorder (MDD) in adults Therapeutic Benefit Vortioxetine Hydrobromide helps support the management of depressive symptoms such as: Persistent low mood Loss of interest or pleasure in …
What is the dosage of Vortiox 10 mg?
The dosage of Vortioxetine Hydrobromide (Vortioxetine) should be individualized based on patient response, tolerability, and clinical condition. It is administered orally once daily , with or without food. Recommended Starting Dose The usual initial dose is 10 mg once daily If tolerated, the dose may be increased to 20 mg once daily Doses above 20 mg/day have not been evaluated for safety or effic…
What are the side effects of Vortiox 10 mg?
Vortioxetine Hydrobromide (Vortioxetine) may cause some adverse effects in certain patients, although not everyone experiences them. Possible Side Effects Hypersensitivity reactions such as rash or itching Worsening depression or suicidal thoughts , especially early in treatment Serotonin syndrome (rare but serious) Abnormal bleeding , particularly with blood thinners or NSAIDs Mania or hypomania …
Who should not take Vortiox 10 mg?
Vortioxetine Hydrobromide is contraindicated in Patients with known hypersensitivity to Vortioxetine or any of the excipients of the drug product & concomitant use of Monoamine Oxidase Inhibitors (MAOIs).
What precautions should be taken with Vortiox 10 mg?
Clinical Worsening & Suicidal Risk Patients receiving antidepressants, including Vortioxetine Hydrobromide, should be closely monitored—especially during the initial weeks of treatment or dose changes—for: Worsening depression Suicidal thoughts or behavior Unusual changes in mood or behavior Serotonin Syndrome A potentially life-threatening condition may occur, particularly when Vortioxetine Hydro…
Is Vortiox 10 mg safe during pregnancy and breastfeeding?
Pregnancy The safety of Vortioxetine Hydrobromide (Vortioxetine) during pregnancy has not been well established. Therefore, it should not be used during pregnancy or in women planning pregnancy , unless the potential benefits clearly outweigh the possible risks to the fetus. Breastfeeding (Lactation) Animal studies suggest that Vortioxetine and its metabolites may be excreted in breast milk , and …
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.